DJIA 17,083.80 -2.83 -0.02%
NASDAQ 4,472.11 -1.59 -0.04%
S&P 500 1,987.98 0.97 0.05%
market minute promo

49.46 0.14 (0.28%)

REAL-TIME: Last trade at

Extended Hours: $49.46 $0.00 (0.00%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

BMY $49.46 0.28%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.96
Previous Close $49.32
Daily Range $48.56 - $49.89
52-Week Range $41.11 - $57.49
Market Cap $82.0B
P/E Ratio 28.51
Dividend (Yield) $1.44 (2.9%)
Ex-Dividend Date
Dividend Pay Date
07/01/14
08/01/14
Volume 8,522,613
Average Daily Volume 7,873,145
Current FY EPS $1.78

Sector

Healthcare

Industry

Drugs

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/

News & Commentary

After Market: Stocks Tumble as a Wind of Caution Chills Wall Street

3 Stocks Improving Performance Of The Health Care Sector

Q2 2014 Bristol Myers Squibb Earnings Conference Call (Webcast)

Sector Update: Health-Care Shares Higher Pre-Market

Sector Update: Health Care

Bristol-Myers profit tops forecasts, helped by newer drugs

Will Bristol-Myers Squibb (BMY) Disappoint This Earnings Season? - Analyst Blog

Whisper Number Impact: What Will Bristol-Myers' Shares Do Post Earnings?

Pre-Market Earnings Report for July 24, 2014 : MMM, UNP, BMY, LLY, CELG, F, CAT, GM, PCP, ALXN, POT

Pre-Market Earnings Report for July 24, 2014 : MMM, UNP, BMY, LLY, CELG, F, CAT, GM, PCP, ALXN, POT, RTN

3 Stocks Reiterated As A Buy: EBAY, BMY, EMC

Galectin Therapeutics Reports First Patient Dosed in Cohort 1 of Phase 1B Clincial Trial of GR-MD-02

Galectin Therapeutics Reports First Patient Dosed in Cohort 1 of Phase 1B Clincial Trial of GR-MD-02 in Combo with Ipilimumab in Metastatic Melanoma

See More BMY News...

BMY's Top Competitors

BMY $49.46 (0.28%)
Current stock: BMY
JNJ $102.20 (0.01%)
Current stock: JNJ
NVS $89.13 (0.12%)
Current stock: NVS
RHHBY $37.24 (1.14%)
Current stock: RHHBY